EVALUATION OF THE AVAILABILITY OF MEDICINES FOR THE TREATMENT OF ENDOMETRIOSIS IN THE SUS IN COMPARISON WITH THE RECOMMENDATIONS OF THE MINISTRY OF HEALTH
Vol. 6 No. 2 (2024), Literature Review
Vol. 6 No. 2 (2024)

EVALUATION OF THE AVAILABILITY OF MEDICINES FOR THE TREATMENT OF ENDOMETRIOSIS IN THE SUS IN COMPARISON WITH THE RECOMMENDATIONS OF THE MINISTRY OF HEALTH

Literature Review
https://doi.org/10.36557/2674-8169.2024v6n2p322-334
Published 2024-02-04
Artur Franco Pinto
Graduando em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Caio Santos Temponi
Graduando em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Érica Luana Silva Veloso
Graduanda em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Hugo Oliveira Mesquita
Graduando em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Letícia Leão Agnello
Graduanda em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Mariana Sardinha de Lisboa Pereira
Graduanda em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Murielle de Almeida Sousa Oliveira
Graduanda em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Ygor Valério Assunção
Graduando em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Isabela Félix Mendonça
Graduanda em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Isabela Nunes Tavares
Graduanda em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Raquel de Oliveira Santos
Graduanda em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
Paulo Henrique Ferreira Messias
Graduando em Medicina pela Faculdade de Medicina, Universidade de Rio Verde – Campus Aparecida Extensão Goiânia, Goiânia - GO
PDF (Português (Brasil))

Keywords

rostatectomy, Prostate, Hyperplasia, Surgical Technique.

How to Cite

Pinto , A. F., Temponi , C. S., Veloso , Érica L. S., Mesquita , H. O., Agnello , L. L., Pereira , M. S. de L., Oliveira , M. de A. S., Assunção , Y. V., Mendonça , I. F., Tavares , I. N., Santos , R. de O., & Messias , P. H. F. (2024). EVALUATION OF THE AVAILABILITY OF MEDICINES FOR THE TREATMENT OF ENDOMETRIOSIS IN THE SUS IN COMPARISON WITH THE RECOMMENDATIONS OF THE MINISTRY OF HEALTH. Brazilian Journal of Implantology and Health Sciences, 6(2), 322–334. https://doi.org/10.36557/2674-8169.2024v6n2p322-334
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Endometriosis affects 7 million women in Brazil, mainly between 25 and 29 years old. This disease occurs when there are parts of the endometrial tissue in extrauterine locations. Its pathophysiological mechanism can be explained by three theories, with retrograde menstruation being the main cause of ectopic implantation of endometrial tissue, which produces local irritation and a series of symptoms. Goals. This article aims to evaluate the treatment for endometriosis available in the National Network of Essential Medicines (RENAME) in comparison with the Clinical Protocol and Therapeutic Guidelines of the Ministry of Health. Methods. This article's methodology is bibliographic research, in which the bibliographic material was based on the use of the Clinical Protocol and Therapeutic Guidelines of the Ministry of Health and the National List of Essential Medicines (RENAME). Results. The 2022 National List of Essential Medicines (RENAME) provides four medicines for the treatment of endometriosis, which are analogues of GnRH and Danazol. While the Clinical Protocol and Therapeutic Guidelines of the Ministry of Health describes six medications as treatment possibilities, being GnRH analogues, progestins, oral contraceptives and Danazol. Conclusion. Given the information collected and the comparisons made, it was possible to identify that the Clinical Protocol and Therapeutic Guidelines of the Ministry of Health on Endometriosis covers a more complete treatment given the many specificities of endometriosis, encompassing treatment for mild and moderate cases with milder adverse effects.

https://doi.org/10.36557/2674-8169.2024v6n2p322-334
PDF (Português (Brasil))

References

- DUNSELMAN, G.A.; VERMEULEN, N.; BECKER, C.; CALHAZ-JORGE, C.; D'HOOGHE, T.; DE BIE, B. et al. ESHRE guideline: management of women with endometriosis. Human Reprod, v. 29, n. 3, pp 400-412, 2014.

- SCHENKEN, R. Overview of the treatment of endometriosis. UpToDate, 2014.

- ABOU-SETTA, A.M.; HOUSTON, B.; AL-INANY, H.G.; FARQUHAR, C. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev., 2013.

- AUST, N.Z.J. Goserelin depot versus danazol in the treatment of endometriosis the Australian/New Zealand experience. Obstet Gynaecol, v. 36, n. 1, pp. 55-60, 1996.

- BELLELIS, P.; DIAS Jr, J. A.; PODGAEC, S.; GONZALES, M.; BARACAT, E. C.; ABRÃO, M. S. (2010). Epidemiological and clinical aspects of pelvic endometriosis: series of cases. Revista da Associação Medica Brasileira, v.56, n.4, 467-471.

- BERGQVIST, A. A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. Gynecol Endocrinol., v. 14, n.6, pp. 425-432, 2000.

- BERGQVIST, A. et al. Effects of triptorelin versus placebo on the symptoms of

endometriosis. Fertil Steril, v.69, n.4, pp. 702-708, 1998.

- BORGES, A. J. S. Aspectos atuais da endometriose. Trabalho de conclusão de curso. Universidade Federal do Maranhão, 2018. Disponível em: http://hdl.handle.net/123456789/2363. Acesso em: 12. out. 2022.

- BROWN, J.; PAN, A.; HART, R.J. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev., v. 12, 2010.

- CROSIGNANI, P.G.; LUCIANO, A.; RAY, A.; BERGQVIST, A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod., v. 21, n. 1, pp. 248-256, 2006.

- Departamento do Sistema Único de Saúde (DATASUS), 2020.

- DULEBA, A. J. Diagnosis of Endometriosis. Obstetrics and Gynecology Clinics of North America, v. 24, n. 2, p. 331–346. 1997.

- HORNSTEIN, M.D.; GIBBONS, W.E. Gonadotropin releasing hormones agonists for long-term treatment of endometriosis. UpToDate, 2014.

- KENNEDY, S.; BERGQVIST, A.; CHAPRON, C.; D’HOOGHE, T.; DUNSELMAN, G.; GREB, R.; SARIDOGAN, E.. ESHRE guideline for the diagnosis and treatment of endometriosis. Human reproduction, v.20, n.10, pp. 2698-2704, 2005.

- KIMBAKLL, K. J. et al. Diffuse Endometritis in the Setting of Umbilical Endometriosis: A Case Report. PMC, 2012. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252021/?tool=pubmed. Acesso em: 12. out. 2022.

- LOVERRO, G. et al. Um estudo randomizado comparando triptorelina ou conduta expectante após cirurgia laparoscópica conservadora para endometriose sintomática estágio III-IV. Eur J Obstet Gynecol Reprod Biol., v. 136, n. 2, pp. 194-198, 2008.

- MATZUK, M. M.; LAMB, D. J. The biology of infertility: research advances and clinical challenges. Nat. Med., v. 14, n. 11, p. 1197-1213, 2008.

- MOGHISSI, K.S. Medical treatment of endometriosis. Clin Obstet Gynecol., v. 42, n.3, pp. 620-632, 1999.

- Protocolo Ginecologia Endometriose. FEBRASGO, n. 78, 2021

- ROCK, J.A.; TRUGLIA, J.A.; CAPLAN, R.J. Zoladex (implante de acetato de goserelina) no tratamento da endometriose: uma comparação randomizada com danazol. Obstet Gynecol., v.82, n.2, pp. 198-205, 1993.

- SCHENKEN, R. S. Endometriosis: Pathogenesis, clinical features, and diagnosis. 2016. Disponível em: https://www.uptodate.com/contents/endometriosis-pathogenesis-clinical-features-and-diagnosis?. Acesso em: 12. out. 2022.

- SCHLAFF, W.D.; CARSON, S.A.; LUCIANO, A.; ROSS, D.; BERGQVIST, A. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril., v. 85, n. 2, pp 314-325, 2006.

- SELAK, V.; FARQUHAR, C.; PRENTICE, A.; SINGLA, A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev., 2007.

- SHAW, R.W. Um estudo comparativo randomizado aberto do efeito do depósito de goserelina e danazol no tratamento da endometriose. Fertil Steril, v.58, n.2, pp. 265-272, 1992.

- YANG, D.X.; MA W.G.; QU F.; MA, B.Z. Estudo comparativo da eficácia de Yiweining e Gestrinone no tratamento pós-operatório da endometriose estágio III.. Chin J Integr Med., v. 12, n. 3, pp. 218-20, 2006.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Artur Franco Pinto , Caio Santos Temponi , Érica Luana Silva Veloso , Hugo Oliveira Mesquita , Letícia Leão Agnello , Mariana Sardinha de Lisboa Pereira , Murielle de Almeida Sousa Oliveira , Ygor Valério Assunção , Isabela Félix Mendonça , Isabela Nunes Tavares , Raquel de Oliveira Santos , Paulo Henrique Ferreira Messias